Topical Steroid Withdrawal is a Targetable Excess of Mitochondrial NAD.
Shobnam N, Saksena S, Ratley G, Yadav M, Chaudhary PP, Sun AA, Howe KN, Gadkari M, Franco LM, Ganesan S, McCann KJ, Hsu AP, Kanakabandi K, Ricklefs S, Lack J, Yu W, Similuk M, Walkiewicz MA; NIAID Centralized Sequencing Program; Gardner DD, Barta K, Tullos K, Myles IA.
Shobnam N, et al. Among authors: tullos k.
medRxiv [Preprint]. 2024 Apr 19:2024.04.17.24305846. doi: 10.1101/2024.04.17.24305846.
medRxiv. 2024.
PMID: 38712043
Free PMC article.
Preprint.